about
Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetu...
Read More
219.82
4.73
(2.20%)
2.5M
XNAS Volume
XNAS 07 May, 2026 5:30 PM (EDT)
Board Meeting
The next board meeting for Natera Inc is on 08 May 2026 for the purpose of Natera Inc First Quarter Earnings Results for 2026
See details
Low Financial Strength
Expensive Valuation
Technically Moderately Bullish
Momentum Trap
These stocks have weak financials and expensive valuation. Buying interest may quickly dissipate. Investors should exercise caution
View Similar
Embed DVM
Natera Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..